(Reuters) - Eli Lilly's stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street estimates, marking the second time sales have disappointed ...

All of the above awards are generously funded by Lilly Board member and producer Stacey Mindich. The winner of the $10,000 Creative Spirit Award in Design, funded by Daryl Roth, is lighting ...

Shares of Eli Lilly were taking a 6.9% hit toward a two ... for its biggest one-day drop since the 9.1% selloff on March 15, 2021. Despite the stock's reaction, Citi Research analyst Geoff Meacham ...

Lilly's stock went on a tear in the beginning of 2023, with the company's shares doubling as investors bet on the drug's popularity. The stock stumbled in October last year, after Zepbound's sales ...

(Reuters) -Eli Lilly's stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street estimates, marking the second time sales have disappointed ...